As CRISPR-based gene editing rapidly advances toward clinical applications, the precise detection of off-target effects has become a critical pillar for ensuring therapeutic safety and efficacy.
Prime editing represents a transformative advance in precision genome editing, yet its efficacy is critically dependent on the design of the prime editing guide RNA (pegRNA).
This guide provides researchers, scientists, and drug development professionals with a comprehensive framework for diagnosing and resolving low CRISPR-Cas9 editing efficiency.
Homology-Directed Repair (HDR) is the cornerstone of precise CRISPR-Cas9 genome editing, enabling targeted gene insertions, corrections, and the creation of sophisticated disease models.
This article provides researchers, scientists, and drug development professionals with a comprehensive, up-to-date guide on addressing CRISPR off-target effects.
This comprehensive review examines current CRISPR-Cas9 gene therapy protocols for sickle cell anemia, targeting researchers and drug development professionals.
This article provides a comprehensive resource for researchers and drug development professionals on leveraging CRISPR-Cas12a for advanced multiplexed genome editing in mouse models.
This article explores Programmable Chromosome Engineering (PCE), a revolutionary set of technologies that enable precise, large-scale DNA manipulations from kilobase to megabase scales.
This article provides a comprehensive overview of prime editing, a versatile 'search-and-replace' genome editing technology that enables precise base substitutions, insertions, and deletions without inducing double-strand DNA breaks.
This article provides researchers, scientists, and drug development professionals with a complete roadmap for successfully generating and validating CRISPR-Cas9 knockout cell lines.